Conclusions
The development of vaccines that would induce specific immune responses in the genital tract secretions would have far-reaching implications for not only the prevention of AIDS and sexually transmitted diseases but also the immunological control of fertility (4, 76, 88, 89, 123, 124, 149). Most of the currently studied vaccines utilize systemic routes of immunization which are of limited value for the prevention of mucosa-contracted diseases. The relative contribution of antigensensitized cells from PP or other inductive sites (e.g., rectal tonsils) to remote or adjacent effector sites (e.g., genital tract) as manifested by the appearance of corresponding S-IgA antibodies has not been studied extensively in humans despite its unquestionable practical importance. Exploration of immunization routes that are effective for induction of mucosal immune responses and that are based primarily on current knowledge of the origin of antibodies and of specific antibody-forming cells in mucosal tissues, together with novel antigen delivery systems (1, 76, 89, 130), is likely to reduce the incidence of many infectious diseases including AIDS and also reduce the cost of administration of such vaccines.
Article PDF
Similar content being viewed by others
References
McGhee JR, Mestecky J: In defense of mucosal surfaces: development of novel vaccines for IgA responses at the portals of entry of microbial pathogens. Infect Dis Clin No Am 4:315–341, 1990
Alexander NJ: Sexual transmission of human immunodeficiency virus: Virus entry into the male and female genital tract. Fertil Steril 54:1–18, 1990
deSchryver A, Meheus A: Epidemiology of sexually transmitted diseases: The global picture. Bull WHO 68:639–654, 1990
Forrest BD: The need for consideration of mucosal immunity in vaccine approaches to AIDS. Vaccine Res 1:137–142, 1992
Hospedales J: Heterosexual spread of HIV infection. Rev Infect Dis 11:663–665, 1989
Johnson AM: Heterosexual transmission of human immunodeficiency virus. Br Med J 296:1017–1020, 1988
McGhee JR, Mestecky J: The mucosal immune system in HIV infection and prospects for mucosal immunity to AIDS. AIDS Res Rev 2:289–312, 1992
Miller CJ, McGhee MR, Gardner MB: Mucosal immunity, HIV transmission, and AIDS. Lab Invest 68:129–145, 1992
Padian N, Wiley J, Winkelstein W: Male-to-female transmission of human immunodeficiency virus (HIV): Current results, infectivity rates, and San Francisco population seroprevalence estimates. 3rd International Conference on AIDS, Washington, DC, 1987, abstr THP 48
Piot P, Plummer F, Mhalu FS, Lamboray JL, Chin J, Mann JM: AIDS: An international perspective. Science 239:573–579, 1988
Forrest BD: Women, HIV, and mucosal immunity. Lancet 1 (337):835–836, 1991
Padian NS, Shiboski SC, Jewell NP: Female to male transmission of human immunodeficiency virus. JAMA 266:1664–1667, 1991
Alley CD, Mestecky J: The mucosal immune system.In B Lymphocytes in Human Disease, G Bird, JE Calvert (eds). Oxford, Oxford University Press, 1988, pp 222–254
Conley ME, Delacroix DL: Intravascular and mucosal immunoglobulin A: Two separate but related systems of immune defense? Ann Intern Med 106:892–899, 1987
Mestecky J, McGhee JR: Immunoglobulin A (IgA): Molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 40:153–245, 1987
Mestecky J: The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol 7:265–276, 1987
Lehner T, Panagiotidi C, Bergmeier LA, Ping T, Brookes R, Adams SE: A comparison of the immune responses following oral, vaginal, or rectal route of immunization with SIV antigens in nonhumans primates. Vaccine Res 1:319–330, 1992
Walker RI: New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 12:387–397, 1994
Husband AJ: Novel vaccination strategies for the control of mucosal infection. Vaccine 11:107–112, 1993
Gilligan CA, Li Wan Po A: Oral vaccines: Design and delivery. Int J Pharm 75:1–24, 1991
O'Hagan DT: Microparticles as oral vaccines.In Novel Delivery Systems for Oral Vaccines, O'Hagan DT (ed). Boca Raton, FL, CRC Press, 1994, pp 175–205
Kilian M, Mestecky J, Russell MW: Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial Immunoglobulin A proteases. Microbiol Rev 52:296–303, 1988
Liew FY, Russell SM, Appleyard G, Brand CM, Beale J: Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur J Immunol 14:350, 1984
Mestecky J, McGhee JR: New strategies for oral immunization. Curr Top Microbiol Immunol 146:3–11, 1989
Miller CJ, Alexander NJ, Sutjipto S, Lackner AA, Gettie A, Hendrickx AG, Lowenstine LJ, Jennings M, Marx PA: Genital mucosal transmission of simian immunodeficiency virus: Animal model for heterosexual transmission of human immunodeficiency virus. J Virol 63:4277–4284, 1989
Marx PA, Compans RW, Gettie A, Staas JK, Gilley RM, Mulligan MJ, Yamschikov GV, Chen D, Eldridge JH: Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260:1323–1327, 1993
Hearst N, Hulley SB: Preventing the heterosexual spread of AIDS. Are we giving our patients the best advice? JAMA 259:2428–2432, 1988
Lawrence DN, Jason JM, Holman RC, Murphy JJ: HIV transmission from hemophiliac men to their heterosexual partners.In Heterosexual transmission of AIDS, Alexander NJ, Gablenick HL, Spieler JM (eds). New York, Alan R. Liss, 1990, pp 35–53
Peterman TA, Stoneburner RL, Allen JR, Jaffe HW, Curran JW: Risk of human immunodeficiency virus from heterosexual adults with transfusion associated infections. JAMA 259:55–58, 1988
Staskewski S, Schieck E, Rehmet S, Helm EB, Stille W: HIV transmission from a male after only two sexual contacts. Lancet 2:628, 1987
Holmberg SD, Stewart JA, Gerber AR, Byers RH, Lee FK, O'Malley PM,et al.: Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 259: 1048–1050, 1988
Holmes KK, Kreiss J: Heterosexual transmission of human immunodeficiency virus: overview of a neglected aspect of the AIDS epidemic. J AIDS 1:602–610, 1988
Plummer FA, Simonsen JN, Cameron DW, Ndinya-Achola JO, Kreiss JK, Gakinya MN, Waiyaaki P, Cheang M, Piot P, Ronald AR, Ngugi EN: Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 163:233–239, 1991
Simonsen JN, Cameron DW, Gakinya MN, Ndinya-Achola JO, D'Costa LJ, Karasira P, Cheang M, Ronald AR, Piot P, Plummer FA: Human immunodeficiency virus infection among men with sexually transmitted diseases. Experience from a center in Africa. N Engl J Med 319:274–278, 1988
Stewart GJ, Cunningham AL, Driscoll GL, Tyler JPP, Barr JA, Gold J, Lamont BJ: Transmission of human T-cell lymphotropic virus type III (HTLV III) by artificial insemination by donor. Lancet 2:581–584, 1985
Chiasson MA, Stoneburner RL, Joseph SC: Human immunodeficiency virus transmission through artificial insemination. J AIDS 3:69–72, 1990
Miller CJ, Alexander NJ, Sutjipto S, Joye SM, Hendrickx AG, Jennings M, Marx PA: Effect of virus dose and nonoxynol-9 on the genital transmission of SIV in rhesus macaques. J Med Primatol 19:401–409, 1990
Miller CJ, Alexander NJ, Vogel P, Anderson J, Marx PA: Mechanism of genital transmission of SIV: a hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. J Med Primatol 21:64–68, 1992
Pauza CD, Emau P, Salvato MS, Trivedi P, MacKenzie D, Malkovsky M, Uno H, Schultz KT: Pathogenesis of SIVmac251 after atraumatic inoculation of the rectal mucosa in rhesus monkeys. J Med Primatol 22:154–161, 1993
Fultz PN, McClure HM, Daugharty H, Brodie A, McGrath CR, Swenson B, Francis DP: Vaginal transmission of human immunodeficiency virus (HIV) to a chimpanzee. J Infect Dis 154:896–900, 1986
Edwards JNT, Morris HB: Langerhans' cells and lymphocyte subsets in the female genital tract. Brit J Obstet Gynaecol 92:974–982, 1985
Pomerantz RJ, de la Monte SM, Donegan SP, Rota TR, Vogt MW, Craven DE, Hirsch MS: Human immunodeficiency virus (HIV) infection of the uterine cervix. Ann Intern Med 108:321–327, 1988
Pudney JA, Anderson DJ: Organization of immunocompetent cells and their function in the male reproductive tract.In Local Immunity in Reproductive Tract Tissues, Griffin PD, Johnson PM (eds). Delhi, Oxford University Press, 1993, pp 131–145
Ullrich R, Zeitz M, Riecken E-O: Enteric immunologic abnormalities in human immunodeficiency virus infection. Sem Liver Dis 12:167–174, 1992
Nelson JA, Wiley CA, Reynolds-Kohler C, Reese CE, Mergaretten W, Levy JA: Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet 1:259–262, 1988
Mathijis JM, Hing M, Grierson J, Dwyer DE, Goldschmidt C, Cooper DA, Cunningham AL: HIV infection of rectal mucosa. Lancet 1:1111, 1988
Adachi A, Koenig S, Gendelman HE, Daugherty D, Gattoni-Celli S, Fauci AS, Martin MA: Productive persistent infection of human colorectal lines with human immunodeficiency virus. J Virol 61:209–213, 1987
Omary MB, Brenner DA, de Grandpre LY, Roebuck KA, Richman DD, Kagnoff MF: HIV-1 infection and expression in human colonic cells: Infection and expression in CD4+ and CD4- cell lines. AIDS 5:275–281, 1991
Phillips DM, Bourinbaiar AS: Mechanism of HIV spread from lymphocytes to epithelia. Virology 186:261–273, 1991
Moyer MP, Huot RI, Aramirez J, Joe S, Meltzer MS, Gendelman HE: Infection of human gastrointestinal cells by HIV-1. AIDS Res Hum Retrovir 6:1409–1415, 1990
Moyer MP, Ramirez A, Woolf A, Huot RI, McKee-Suarez MS: HIV infection of human gastrointestinal submucosal cells: Anin vitro model that mimics Kaposi's sarcoma. In Vitro Cell Dev Biol 27A:337–344, 1991
Yahi N, Baghdiguian S, Moreau H, Fantini J: Galactosylceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colonic epithelial HT29 cells. J Virol 66:4848–4854, 1992
Amerongen HM, Weltzin R, Farnet CM, Michetti P, Haseltine WA, Neutra MR: Transepithelial transport of HIV-1 by intestinal M cells: A mechanism for transmission of AIDS. J AIDS 4:760–765, 1991
Kato T, Owen RL: Structure and function of intestinal mucosal epithelium.In Handbook of Mucosal Immunology, Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J (eds). San Diego, Academic Press, 1994, pp 11–26
Kotler DP, Gaetz HP, Klein EB, Lange M, Holt PR: Enteropathy associated with the acquired immunodeficiency virus. Ann Intern Med 101:421–428, 1984
Ullrich R, Zeitz M, Heise M, L'age M, Hoffken G, Reicken EO: Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV). Evidence for HIV-induced enteropathy. Ann Intern Med 111: 15–21, 1989
Fantini J, Yahi N, Baghdiguian S, Chermann J-C: Human colon epithelial cells productively infected with human immunodeficiency virus show impaired differentiation and altered secretion. J Virol 66:580–585, 1992
Fantini J, Yahi N, Baghdiguian S, Spitalnik SL, Gonzalez-Scarano F: Human immunodeficiency virus infection of human intestinal epithelial cells. Mucosal Immunol Update 2:1–13, 1994
Brandtzaeg P: Overview of the mucosal immune system. Curr Top Microbiol Immunol 146:13–25, 1989
McGhee JR, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M, Kiyono H: The mucosal immune system: From fundamental concepts to vaccine development. Vaccine 10:75–88, 1992
Brandtzaeg P, Nilssen DE, Rognum TO: Ontogeny of the mucosal immune system and IgA deficiency. Gastroenterol Clin No Am 20:397–439, 1991
Brandtzaeg P: The role of J chain and secretory component in receptor-mediated glandular and hepatic transport of immunoglobulins in man. Scand J Immunol 22:111–146, 1985
Mestecky J, Tomana M, Zikan J, Moldoveanu Z, Moro I, Komiyama K, Radl J, Thorpe SR, Phillips JO, Everson MP, Kulhavy R, Lue C: Life history of human IgA: The role of receptors in its distribution and catabolism.In Frontiers of Mucosal Immunology, M Tsuchiya, H Nagura, T Hibi, I Moro (eds). Amsterdam/New York, Excerpta Medica, 1991, pp 3–12
Mestecky J, Lue C, Russell MW: Selective transport of IgA. Cellular and molecular aspects. Gastroenterol Clin No Am 20:441–471, 1992
Onorato IM, Modlin JF, McBean AM, Thoms ML, Losonsky GA, Bernier RH: Mucosal immunity induced by enhance-potency inactivated and oral polio vaccine. J Infect Dis 163:1–6, 1991
Scicchitano R, Stanisz A, Ernst PB, Bienenstock J: A common immune system revisited.In Migration and Homing of Lymphoid Cells, Husband AJ (ed). Boca Raton, FL, CRC Press, 1988, pp 1–34
Phillips-Quagliata JM, Lamm ME: Migration of lymphocytes in the mucosal immune system.In Migration and Homing of Lymphoid Cells, Husband AJ (ed). Boca Raton, FL, CRC Press, 1988, pp 53–75
Lefrancois L: TCRγδ T cells: Do they have potential for anti-HIV activity? Vaccine Res 1:203–206, 1992
Cebra JJ, Gearhart PJ, Kamat R, Robertson SM, Tseng J: Origin and differentiation of lymphocytes involved in the secretory IgA response. Quant Biol 41:201–215, 1977
McGhee JR, Mestecky J, Elson CO, Kiyono H: Regulation of IgA synthesis and immune response by T cells and interleukins. J Clin Immunol 9:175–199, 1989
Strober W, Ehrhardt RO: Regulation of IgA B cell development.In Handbook of Mucosal Immunology, PL Ogra, ME Lamm, JR McGhee, J Mestecky, W Strober, J Bienenstock (eds). San Diego, Academic Press, 1994, pp 159–176
Montgomery PC, Cohn J, Lally ET: The induction and characterization of secretory antibodies. Adv Exp Med Biol 45:453–462, 1974
Czerkinsky C, Svennerholm A-M, Quiding M, Jonsson R, Holmgren J: Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans. Infect Immun 59:996–1001, 1991
Czerkinsky C, Prince SJ, Michalek SM, Jackson S, Russell MW, Moldoveanu Z, McGhee JR, Mestecky J: IgA antibody-producing cells in peripheral blood after antigen ingestion: Evidence for a common mucosal immune system in humans. Proc Natl Acad Sci USA 84:2449–2453, 1987
Kantele A, Kantele JM, Avrilommi H, Makela PH: Active immunity is seen as a reduction in the cell response to oral live vaccine. Vaccine 9:428–431, 1991
Mestecky J, McGhee JR: Prospects for human mucosal vaccines. Adv Exp Med Biol 327:13–23, 1992
Brandtzaeg P, Halstensen TS: Immunology and immunopathology of tonsils. Adv Otorhinoloaryngol 47:64–75, 1992
Nadal D, Ogra PL: Tonsils: The gatekeeper of mucosal immunity. Adv Otorhinolaryngol 47:76–79, 1992
Dolen WK, Spofford B, Selner JC: The hidden tonsils of Waldeyer's ring. Ann Allergy 65:244–248, 1990
Ogra PL: Effect of tonsillectomy and adenoidectomy on nasopharyngeal antibody response to poliovirus. N Engl J Med 284:59–64, 1979
O'Leary AD, Sweeney EC: Lymphoglandular complexes of the colon: structure and distribution. Histopathology 10:267–283, 1986
Langman JM, Rowland R: The number and distribution of lymphoid follicles in the human large intestine. J Anat 194:189–194, 1986
Strindel H: “Tonsille des Mastdarmes” und ihre Stellung in der Pathologie des lymphatischen Apparates des Mastdarme. Zbl Chirurgie 62:2594–2607, 1935
Crago SS, Kutteh WH, Moro I, Allansmith MR, Radl J, Haaijman JJ, Mestecky J: Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues. J Immunol 132: 16–18, 1984
Kett K, Brandtzaeg P, Radl J, Haaijman JJ: Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. J Immunol 136:3631–3636, 1986
Mestecky J, Russell MW: IgA subclasses. Monogr Allergy 19:277–301, 1986
Kutteh WH, Hatch KD, Blackwell RE, Mestecky J: Secretory immune system of the female reproductive tract. I. Immunoglobulin and secretory component-containing cells. Obstet Gynecol 71:56–60, 1988
Kutteh WH, Edwards RP, Menge AC, Mestecky J: IgA immunity in female reproductive tract secretions.In Local Immunity in Reproductive Tract Tissues, PD Griffin, PM Johnson (eds). Delhi, Oxford University Press, 1993, pp 229–243
Drew MD, Rosenthal KL, McDermott MR: The design of vaccines for inducing secretory immunity in the reproductive tract.In Local Immunity in Reproductive Tract Tissues, PD Griffin, PM Johnson (eds). Delhi, Oxford University Press, 1993, pp 483–514
Tjokronegoro A, Sirisinha S: Quantitative analysis of immunoglobulins and albumin in secretion of female reproductive tract. Fertil Steril 26:413–417, 1975
Kutteh WH, Mestecky J: Secretory immunity in the female reproductive tract. Amer J Reprod Immunol 31:40–46, 1993
Jalanti R, Islikes H: Immunoglobulins in human cervicovaginal secretions. Int Arch Allergy Appl Immunol 53:402–409, 1977
Parr EL, Parr MA: A comparison of antibody titres in mouse uterine fluid after immunization by several routes, and the effect of the uterus on antibody titres in vaginal fluid. J Reprod Fertil 89:619–625, 1990
Tourville DR, Ogra SS, Lippes J, Tomasi TB: The human female reproductive tract: immunohistological localization of γgA, γgG, γgM, secretory “piece,” and lactoferrin. Am J Obstetr Gynecol 108:1102–1108, 1970
Putkonen P, Thorstensson R, Ghavamzadeh L, Albert J, Hild K, Biberfeld G, Norrby E: Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys. Nature 352:436–438, 1991
Levy JA: The transmission of AIDS: The case of the affected cell. JAMA 259:3037–3038, 1988
Levy JA: Human immunodeficiency virus and the pathogenesis of AIDS. JAMA 261:2997–3006, 1989
Mazanec MB, Kaetzel CS, Lamm ME, Fletcher D, Nedrud JG: Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci USA 89:6901–6905, 1992
Monteiro RC, Kubagawa H, Cooper MD: Cellular distribution, regulation, and biochemical nature of an Fcα receptor in humans. J Exp Med 171:597–613, 1990
Lamm ME, Mazanec MB, Nedrud JG, Kaetzel CS: Mechanisms of IgA-mediated mucosal defense. Vaccine Res 1:169–173, 1992
Muller F, Froland SS, Hvatum M, Radl J, Brandtzaeg P: Both IgA subclasses are reduced in parotid saliva from patients with AIDS. Clin Exp Immunol 83:203–209, 1991
Jackson S: Secretory and Serum IgA are Inversely Altered in AIDS Patients.In Advances in Mucosal Immunology, T MacDonald, SJ Challacombe, PW Bland, CR Stokes, RV Heatley, AMcl Mowat (eds). Hingham, MA, Kluwer Academic, 1990 pp 665–666
Janoff EN, Jackson S, Wahl SM, Thomas K, Smith PD: Dysregulation of intestinal mucosal antibodies during HIV-1 infection. J Infect Dis (in press)
Kotler DP, Scholes JV, Tierney AR: Intestinal plasma cell alterations in the acquired immunodeficiency syndrome. Dig Dis Sci 32:129–138, 1987
Mestecky J, Russell MW, Jackson S, Brown TA: The human IgA system: A reassessment. Clin Immunol Immunopathol 40:105–114, 1986
Kilian M, Russell MW: Function of mucosal immunoglobulins.In Handbook of Mucosal Immunology, PL Ogra, ME Lamm, JR McGhee, J Mestecky, W Strober, J Bienenstock (eds). San Diego, Academic Press, 1994, pp 127–138
Kozlowski PA, Cheng D, Eldridge JH, Jackson S: Contrasting IgA and IgG neutralization capacities and responses to the HIV-1 gp120 V3 loop in HIV-infected individuals. AIDS Res Hum Retrovir (in press)
Burnett PR, VanCott TC, Polonis VR, Redfield RR, Birx DL: Serum IgA-mediated neutralization of HIV type 1. J Immunol 152:4642–4648, 1994
Black KP, Jackson S: Serum IgA from HIV-seropositive individuals mediates antibody dependent cellular cytotoxicity against HIV-infected cells (submitted for publication)
Burke DS: Human HIV vaccine trials: does antibody-dependent enhancement pose a genuine risk? Perspect Biol Med 35:511–530, 1992
Takeda A, Ennis FA: FcR-mediated enhancement of HIV-1 infection by antibody. AIDS Res Hum Retrovir 6:999–1004, 1990
Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ: IgA-induced eosinophil degranulation. J Immunol 142:2393–2400, 1989
Jackson S, Dawson LM, Kotler DP: IgA1 is the major immunoglobulin component of immune complexes in the acquired immune deficiency syndrome. J Clin Immunol 8:64–68, 1988
Lightfoote MM, Folks TM, Redfield R, Gold J, Sell KW: Circulating IgA immune complexes in AIDS. Immunol Invest 14:341–345, 1985
Hussain LA, Kelly CG, Hecht E-M, Fellowes R, Jourdan M, Lehner T: The expression of Fc receptors for immunoglobulin G in human rectal epithelium. AIDS 5:1089–1094, 1991
Sixbey JW, Yao Q-Y: Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science 255:1578–1580, 1992
Matsuda S, Oka S, Honda M, Takebe Y, Takemori T: Characterization of IgA antibodies against HIV-1 in sera and saliva from HIV-seropositive individuals in different clinical stages. Scand J Immunol 38:428–434, 1993
Kozlowski P, Jackson S: Serum IgA subclasses and molecular forms in HIV infection: Selective increases in monomer and apparent restriction of the antibody response to IgA1 antibodies mainly directed atenv glycoproteins. AIDS Res Hum Retrovir 8:1773–1779, 1992
Miller CJ: Use of the SIV/rhesus macaque model of the heterosexual transmission of HIV in AIDS vaccine research. Vaccine Res 1:295–301, 1992
Lehner T, Brookes R, Panagiotidi C, Tao L, Klavinskis LS, Walker J, Walker P, Ward R, Hussain L, Gearing AJH, Adams SE, Bergmeier LA: T- and B-cell functions and epitope expression in nonhuman primates immunized with simian immunodeficiency virus antigen by the rectal route. Proc Natl Acad Sci USA 90:8638–8642, 1993
Lehner T, Bergmeier LA, Panagiotidi C, Tao L, Brookes R, Klavinskis LS, Walker P, Walker J, Ward RG, Hussain L, Gearing AJH, Adams SE: Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 258:1365–1369, 1992
Vaerman J-P, Ferin J: Local immunological response in the vagina, cervix, and endometrium.In Immunological Approaches to Fertility Control, E Diczfalusy (ed). Stockholm, Karolinska Institute, 1974, pp 281–305
Roche JK, Crum CP: Local immunity and the uterine cervix: Implications for cancer-associated viruses. Cancer Immunol Immunother 33:203–209, 1991
Parr EL, Parr MB: Immunization for a secretory immune response in the female reproductive tract. Vaccine Res 1:221–225, 1992
Thapar MA, Parr EL, Bozzala JJ, Parr MB: Secretory immune responses in the mouse vagina after pelvic, parenteral or vaginal immunization. Immunology 70:129–134, 1991
Kroese RGM, Butcher EC, Stall AM, Lalor PA, Adams S, Herzenberg LA: Many of the IgA-producing plasma cells in the murine gut are derived from self replenishing precursors in the peritoneal cavity. Internat Immunol 1:75–84, 1989
Allardyce RA, Rademaker M: Female genital tract immunity and infertility after oral vaccination with sperm antigens in mice. Adv Exp Med Biol 216B:1807–1813, 1987
Waldman RH, Cruz JM, Rowe DS: Intravaginal immunization of humans withCandida albicans. J Immunol 109:662–664, 1972
Bronson RA, Fusi FM: Immunologically mediated male and female reproductive failure.In Handbook of Mucosal Immunology, PL Ogra, ME Lamm, JR McGhee, J Mestecky, W Strober, J Bienenstock (eds). San Diego, Academic Press, 1994, pp 691–703
Mestecky J, Eldridge JH: Targeting and controlled release of antigens for the effective induction of secretory antibody responses. Curr Opin Immunol 3:492–495, 1991
Michalek SM, Eldridge JH, Curtiss III RC, Rosenenthal KL: Antigen delivery systems: New approaches to mucosal immunization.In Handbook of Mucosal Immunology, PL Ogra, ME Lamm, JR McGhee, J Mestecky, W Strober, J Bienenstock (eds). San Diego, Academic Press, 1994, pp 373–390
Cardenas L, Clements JD: Oral immunization using live attenuatedSalmonella spp. as carriers of foreign antigens. Clin Microbiol Rev 5:328–342, 1992
Curtiss R, Kelly SM, Gulig PA, Nakayama K: Selective delivery of antigens by recombinant bacteria. Curr Top Microbiol Immunol 146:35–49, 1989
Schodel F: Oral immunization using recombinant bacteria. Semin Immunol 2:341–349, 1990
Aldovini A, Young RA: Humoral and cell-mediated immune response to live recombinant BCG-HIV vaccine. Nature 351:479–482, 1991
Charbit A, Martineau P, Ronco J, Leclerc C, Lo-Man R, Michel V, O'Callaghan D, Hofnung M: Expression and immunogenicity of the V3 loop from the envelope of human immunodeficiency virus type 1 in an attenuated aro A strain ofSalmonella typhimurium upon genetic coupling to twoEscherichia coli carrier proteins. Vaccine 11:1221–1228, 1993
Lagranderie M, Murray A, Gicquel B, Leclerc C, Gheorghiu M: Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen. Vaccine 11:1283–1290, 1993
Stover CK, de la Cruz VF, Fuerst TR, Burlein JE, Benson LA, Bennett LT, Bansal GP, Young JF, Lee MH, Hatfull GF, Snapper SB, Barletta RG, Jacobs WR, Bloom BR: New use of BCG for recombinant vaccines. Nature 351: 456–459, 1991
Porter DC, Ansardi DC, Choi WS, Morrow CD: Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 gag and pol proteins upon infection. J Virol 67:3712–3719, 1993
Natuk RJ, Lubeck MD, Davis AR, Chengalvala M, Chanda PK, Mizutani S, Eichberg JW, Hung PP: Adenovirus as a vector system for induction of secretory immunity. Vaccine Res 1:275–283, 1992
Ogra PL, Karzon DT, Righthand I, Macgillivray M: Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. N Engl J Med 279:893–900, 1968
Hansen J-ES, Hofmann B, Sorensen T, Clausen H: Role of carbohydrate on HIV and possibilities for anti-viral intervention.In Complex Carbohydrates in Drug Research, K Bock, H Clausen (eds). Alfred Benzon Symposium 36, Copenhagen, Munksgaard, 1994, pp 414–427
Mason HS, Lam D-K, Arntzen CJ: Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci USA 89:11745–11749, 1992
Holmgren J, Lycke N, Czerkinsky C: Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 11:1179–1184, 1993
Elson CO, Dertzbaugh MT: Mucosal adjuvants.In Handbook of Mucosal Immunology, PL Ogra, ME Lamm, JR McGhee, J Mestecky, W Strober, J Bienenstock (eds). San Diego, Academic Press, 1994, pp 391–402
Quiding M, Nordstrom A, Kilander A, Andersson G, Hanson LA, Holmgren J, Czerkinsky C: Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-γ production and evokes local immunological memory. J Clin Invest 88:143–148, 1991
Moldoveanu Z, Novak M, Huang W-Q: Oral immunization with influenza virus in biodegradable microspheres. J Infect Dis 167:84–90, 1993
Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL: DNA vaccines: protective immunizations by parental, mucosal and gene-gun inoculations. Proc Natl Acad Sci USA 90:11478–11482, 1993
Alexander NJ, Fulgham DL, Goldberg E: Contraceptive vaccine development: Secretory immune response in mice and monkeys. Vaccine Res 1:331–346, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mestecky, J., Jackson, S. Reassessment of the impact of mucosal immunity in infection with the human immunodeficiency virus (HIV) and design of relevant vaccines. J Clin Immunol 14, 259–272 (1994). https://doi.org/10.1007/BF01540979
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01540979